PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer. PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. PTC-028 downregulates BMI-1, inducing caspase-mediated apoptosis[1].
Molecular Weight:
405.32
Purity:
98
CAS Number:
[1782970-28-8]
Formula:
C19H12F5N5
Target:
Apoptosis,BMI1
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted